Stock Markets April 23, 2026 05:49 AM

EssilorLuxottica Shares Drop as Questions Persist Over Smart-Glasses Growth

Quarterly revenue growth fails to quiet investor concerns about wearables and a demanding 2026 outlook

By Marcus Reed
EssilorLuxottica Shares Drop as Questions Persist Over Smart-Glasses Growth

EssilorLuxottica's stock slid after first-quarter results that matched expectations but did little to alleviate investor unease about the firm's growth trajectory for smart glasses and the challenge of meeting ambitious 2026 targets. Revenue rose 10.8% at constant exchange rates, with Ray-Ban and Oakley leading performance thanks in part to AI-enabled eyewear developed with Meta, but analysts flagged remaining uncertainties about wearable competition and execution risks.

Key Points

  • EssilorLuxottica reported first-quarter revenue up 10.8% at constant exchange rates; Ray-Ban and Oakley led frame performance.
  • Shares fell about 5% in Paris and were the biggest decliner on the CAC 40; stock is down roughly 29% year-to-date.
  • Analysts noted that while short-term slowdown risks appear reassured, longer-term uncertainties and execution on smart glasses remain critical.

Summary: EssilorLuxottica reported first-quarter revenue growth that broadly met market expectations but failed to reverse a slide in its share price as doubts remain about the growth prospects for smart glasses and the feasibility of the company’s near-term targets.

Shares in the Franco-Italian eyewear group fell roughly 5% in Paris on Thursday, making EssilorLuxottica the largest decliner on the blue-chip CAC 40 index. The decline followed a report that group revenue increased 10.8% at constant exchange rates in the first quarter of 2026.

Brand performance was led by Ray-Ban and Oakley, which the company said benefited from AI-enabled frames created in partnership with Meta. Those products were highlighted as top-performing within the group's frame portfolio.

Brokerage and analyst reaction to the quarterly figures was mixed. Italian brokerage Equita described the results as reassuring in terms of short-term slowdown risks, while cautioning that longer-term questions remain. "The questions about competitive pressure on wearables, the contribution to growth of other strategic projects and the resilience of consumption on traditional business remain open and to be monitored," Equita analyst Domenico Ghilotti wrote.

Morgan Stanley noted that trading in April was broadly in line with the first quarter, which helped reduce concerns about exit rates and the current operating environment. The company itself reiterated the outlook it provided in February, restating expectations for solid total revenue growth over the next five years alongside broadly aligned growth in adjusted operating profit.

Kepler Cheuvreux highlighted a tension between the reaffirmed longer-term growth guidance and the nearer-term pacing required to meet current fiscal expectations. The broker said that meeting consensus assumptions for the 2026 fiscal year implies more than 13% growth in the coming quarters, calling that a "demanding target" in light of tougher year-on-year comparisons. "Execution will hinge on the success of new smart glasses models," Kepler said.

The share price has already reflected investor caution: EssilorLuxottica’s stock is down about 29% year-to-date.


Contextual note: The company’s results and analyst commentary show investor focus on wearable technology execution and the resilience of traditional eyewear demand as key determinants of near-term performance.

Risks

  • Competitive pressure in the wearables market could limit growth from AI-enabled smart glasses - impacts technology and consumer electronics sectors.
  • Meeting 2026 fiscal expectations requires more than 13% growth in coming quarters, a demanding target given tougher comparisons - impacts investor returns and equity markets.

More from Stock Markets

RELX Shares Slip After Anthropic Forms Legal AI Partnership with Freshfields Apr 23, 2026 Super Micro Shares Slide After Reported $1.1B-$1.4B Oracle Rack Cancellation Apr 23, 2026 Unprofitable Tech Giants Poised to Drive Largest IPO Wave on Record Apr 23, 2026 Roche CEO Warns Bureaucracy and Pricing Moves Threaten Europe’s Position in Drug Innovation Apr 23, 2026 ServiceNow and IBM results spark broad software selloff amid AI concerns Apr 23, 2026